{ "data": [ { "id": "stat_35B2BZH6FEBNQ6CF9451NP9JEV", "url": "https://statorigin.org/stat/stat_35B2BZH6FEBNQ6CF9451NP9JEV", "indicator": { "slug": "amr-driven-annual-global-gdp-reduction", "name": "AMR-driven annual global GDP reduction", "definition": "Projected annual reduction in global GDP caused by unchecked antimicrobial resistance by 2050." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2050-01-01", "end": "2050-12-31", "type": "year" }, "value": 3.8, "value_text": "3.8%", "unit": "percent", "currency": null, "scale": "1", "value_type": "forecast", "source": { "org": "World Bank", "org_short_name": "World Bank", "org_url": "https://www.worldbank.org", "org_tier": 1, "document_title": "Health Emergencies", "document_url": "https://www.worldbank.org/en/topic/pandemics", "document_type": "press_release", "locator": "Context", "quote": "If unchecked, AMR could reduce global GDP by 3.8% annually by 2050 and push 28 million people into poverty.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "World Bank. (2050). Health Emergencies. Retrieved September 16, 2026, from https://www.worldbank.org/en/topic/pandemics. Via StatOrigin, https://statorigin.org/stat/stat_35B2BZH6FEBNQ6CF9451NP9JEV", "bibtex": "@misc{worldbank2050drivennp9jev,\n author = {{World Bank}},\n title = {Health Emergencies},\n year = {2050},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_35B2BZH6FEBNQ6CF9451NP9JEV},\n note = {Original source: https://www.worldbank.org/en/topic/pandemics. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_QK71C25ECSWX5EXPXESRZ555R9", "url": "https://statorigin.org/stat/stat_QK71C25ECSWX5EXPXESRZ555R9", "indicator": { "slug": "aggregate-revenue-of-patient-organizations", "name": "Aggregate revenue of patient organizations", "definition": "Total combined revenue of patient organizations over a multi-year period." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "US", "name": "United States", "type": "country" }, "period": { "start": "2016-01-01", "end": "2020-12-31", "type": "year" }, "value": 62.5, "value_text": "$62.5 billion", "unit": "USD", "currency": "USD", "scale": "billion", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Supporting patients through research collaboration", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration", "document_type": "press_release", "locator": "Over the past 5 years patient organizations have received over 62.5 billion in revenue", "quote": "Aggregate revenue of U.S. patient organizations exceeded $62.5 billion over the five-year period 2016–2020 (n=3,262), giving them an average of $12.5 billion annually to support their missions.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2020). Supporting patients through research collaboration. Retrieved September 16, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration. Via StatOrigin, https://statorigin.org/stat/stat_QK71C25ECSWX5EXPXESRZ555R9", "bibtex": "@misc{iqvia2020aggregatez555r9,\n author = {{IQVIA Institute}},\n title = {Supporting patients through research collaboration},\n year = {2020},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_QK71C25ECSWX5EXPXESRZ555R9},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_HTN3S09ZN6YTRFG5A3YBJWTHTF", "url": "https://statorigin.org/stat/stat_HTN3S09ZN6YTRFG5A3YBJWTHTF", "indicator": { "slug": "annual-revenue-growth-rate-of-largest-patient-organizations", "name": "Annual revenue growth rate of largest patient organizations", "definition": "Average annual revenue growth rate for the largest patient organizations by revenue tier." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "US", "name": "United States", "type": "country" }, "period": { "start": "2016-01-01", "end": "2020-12-31", "type": "year" }, "value": 5, "value_text": "5% annually", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Supporting patients through research collaboration", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration", "document_type": "press_release", "locator": "Over the past 5 years patient organizations have received over 62.5 billion in revenue", "quote": "However, the top 20% of patient organizations among these (n=377) raised 92% of this revenue and only these largest patient organizations have seen their revenues grow on average (with increases of 5% annually) while others have seen declines.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2020). Supporting patients through research collaboration. Retrieved September 16, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration. Via StatOrigin, https://statorigin.org/stat/stat_HTN3S09ZN6YTRFG5A3YBJWTHTF", "bibtex": "@misc{iqvia2020revenuejwthtf,\n author = {{IQVIA Institute}},\n title = {Supporting patients through research collaboration},\n year = {2020},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_HTN3S09ZN6YTRFG5A3YBJWTHTF},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_4KYVSDW7F7ZQR4H63CZFXATPSK", "url": "https://statorigin.org/stat/stat_4KYVSDW7F7ZQR4H63CZFXATPSK", "indicator": { "slug": "average-annual-revenue-of-patient-organizations", "name": "Average annual revenue of patient organizations", "definition": "Average yearly revenue of patient organizations over a multi-year period." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "US", "name": "United States", "type": "country" }, "period": { "start": "2016-01-01", "end": "2020-12-31", "type": "year" }, "value": 12.5, "value_text": "$12.5 billion", "unit": "USD", "currency": "USD", "scale": "billion", "value_type": "estimate", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Supporting patients through research collaboration", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration", "document_type": "press_release", "locator": "Over the past 5 years patient organizations have received over 62.5 billion in revenue", "quote": "Aggregate revenue of U.S. patient organizations exceeded $62.5 billion over the five-year period 2016–2020 (n=3,262), giving them an average of $12.5 billion annually to support their missions.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2020). Supporting patients through research collaboration. Retrieved September 16, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration. Via StatOrigin, https://statorigin.org/stat/stat_4KYVSDW7F7ZQR4H63CZFXATPSK", "bibtex": "@misc{iqvia2020averagexatpsk,\n author = {{IQVIA Institute}},\n title = {Supporting patients through research collaboration},\n year = {2020},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_4KYVSDW7F7ZQR4H63CZFXATPSK},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/supporting-patients-through-research-collaboration. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_7EVQ7Z8X7CKFJDX11AM1SZB2TT", "url": "https://statorigin.org/stat/stat_7EVQ7Z8X7CKFJDX11AM1SZB2TT", "indicator": { "slug": "covid-19-pandemic-economic-losses", "name": "COVID-19 pandemic economic losses", "definition": "Estimated global economic losses caused by the COVID-19 pandemic." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2020-01-01", "end": "2023-12-31", "type": "year" }, "value": 10, "value_text": "$10 trillion", "unit": "USD", "currency": "USD", "scale": "trillion", "value_type": "estimate", "source": { "org": "World Bank", "org_short_name": "World Bank", "org_url": "https://www.worldbank.org", "org_tier": 1, "document_title": "Health Emergencies", "document_url": "https://www.worldbank.org/en/topic/pandemics", "document_type": "press_release", "locator": "Context", "quote": "Economic losses are estimated to exceed $10 trillion.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "World Bank. (2023). Health Emergencies. Retrieved September 16, 2026, from https://www.worldbank.org/en/topic/pandemics. Via StatOrigin, https://statorigin.org/stat/stat_7EVQ7Z8X7CKFJDX11AM1SZB2TT", "bibtex": "@misc{worldbank2023covidszb2tt,\n author = {{World Bank}},\n title = {Health Emergencies},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_7EVQ7Z8X7CKFJDX11AM1SZB2TT},\n note = {Original source: https://www.worldbank.org/en/topic/pandemics. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_01M2KJ7XCF5037JCNPDKKT7NNS", "url": "https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNS", "indicator": { "slug": "cell-and-gene-therapy-clinical-trial-starts", "name": "Cell and gene therapy clinical trial starts", "definition": "Number of clinical trials of cell and gene therapies started in a given period." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true }, { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": false } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2023-01-01", "end": "2023-12-31", "type": "year" }, "value": 631, "value_text": "631", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies", "document_type": "press_release", "locator": "Cell and gene therapy clinical trial starts by type, 2013-2023", "quote": "Over the last five years 3,285 trials were started to evaluate cell and gene therapies in patients across all sponsor types, including 631 in 2023.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2023). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNS", "bibtex": "@misc{iqvia2023cellkt7nns,\n author = {{IQVIA Institute}},\n title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNS},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_01M2KJ7XCF5037JCNPDKKT7NNR", "url": "https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNR", "indicator": { "slug": "cell-and-gene-therapy-clinical-trial-starts", "name": "Cell and gene therapy clinical trial starts", "definition": "Number of clinical trials of cell and gene therapies started in a given period." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true }, { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": false } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2019-01-01", "end": "2023-12-31", "type": "year" }, "value": 3285, "value_text": "3,285", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies", "document_type": "press_release", "locator": "Cell and gene therapy clinical trial starts by type, 2013-2023", "quote": "Over the last five years 3,285 trials were started to evaluate cell and gene therapies in patients across all sponsor types, including 631 in 2023.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2023). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNR", "bibtex": "@misc{iqvia2023cellkt7nnr,\n author = {{IQVIA Institute}},\n title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNR},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_01M2KJ7XCF5037JCNPDKKT7NNZ", "url": "https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNZ", "indicator": { "slug": "cell-and-gene-therapy-reimbursement-rate", "name": "Cell and gene therapy reimbursement rate", "definition": "Percentage of cell and gene therapies that are reimbursed in a given country or region." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true }, { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": false } ], "region": { "code": "EU", "name": "European Union", "type": "bloc" }, "period": { "start": "2023-04-01", "end": "2023-04-01", "type": "point" }, "value": 42, "value_text": "42%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies", "document_type": "press_release", "locator": "Status of cell and gene therapy reimbursement in Europe (Apr 2023) compared to GDP per capital 2022, current international dollars PPP", "quote": "Within Western Europe, the wealthiest countries — Luxembourg and Switzerland — reimburse fewer therapies (42%) than Germany and France, which have lower GDP per capita but reimburse 75% or more of therapies.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2023). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNZ", "bibtex": "@misc{iqvia2023cellkt7nnz,\n author = {{IQVIA Institute}},\n title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNZ},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_01M2KJ7XCF5037JCNPDKKT7NNE", "url": "https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNE", "indicator": { "slug": "cell-and-gene-therapy-share-of-medicine-spending", "name": "Cell and gene therapy share of medicine spending", "definition": "Percentage of total medicine spending attributable to cell and gene therapies." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true }, { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": false } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2023-01-01", "end": "2023-12-31", "type": "year" }, "value": 0.4, "value_text": "0.4%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies", "document_type": "press_release", "locator": "Key findings", "quote": "Spending on cell and gene therapies is increasing rapidly and reached $5.9Bn in 2023, up 38% from 2022 although spending accounted for only 0.4% of the $1.6Tn spent on medicines globally in 2023.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2023). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNE", "bibtex": "@misc{iqvia2023cellkt7nne,\n author = {{IQVIA Institute}},\n title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNE},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_01M2KJ7XCF5037JCNPDKKT7NNT", "url": "https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNT", "indicator": { "slug": "cell-and-gene-therapy-spending", "name": "Cell and gene therapy spending", "definition": "Total spending on cell and gene therapies in a given year." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true }, { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": false } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2023-01-01", "end": "2023-12-31", "type": "year" }, "value": 5.9, "value_text": "$5.9Bn", "unit": "USD", "currency": "USD", "scale": "billion", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies", "document_type": "press_release", "locator": "Global cell and gene therapy spending and share by geography", "quote": "Global spending on these therapies reached $5.9Bn in 2023.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2023). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNT", "bibtex": "@misc{iqvia2023cellkt7nnt,\n author = {{IQVIA Institute}},\n title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNT},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_01M2KJ7XCF5037JCNPDKKT7NNW", "url": "https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNW", "indicator": { "slug": "cell-and-gene-therapy-spending-average-annual-growth-rate", "name": "Cell and gene therapy spending average annual growth rate", "definition": "Average annual percentage growth in cell and gene therapy spending over a multi-year period." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true }, { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": false } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2019-01-01", "end": "2023-12-31", "type": "year" }, "value": 65, "value_text": "65%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies", "document_type": "press_release", "locator": "Global cell and gene therapy spending and share by geography", "quote": "Spending grew by 38% in 2023 from the prior year, and spending has averaged 65% annual growth over the last five years as more products are reaching the market.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2023). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNW", "bibtex": "@misc{iqvia2023cellkt7nnw,\n author = {{IQVIA Institute}},\n title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNW},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_KZMQKVXHWFTKJV7T310W619CKK", "url": "https://statorigin.org/stat/stat_KZMQKVXHWFTKJV7T310W619CKK", "indicator": { "slug": "cell-and-gene-therapy-spending-growth-rate", "name": "Cell and gene therapy spending growth rate", "definition": "Year-over-year percentage growth in spending on cell and gene therapies." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true }, { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": false } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2023-01-01", "end": "2023-12-31", "type": "year" }, "value": 38, "value_text": "38%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies", "document_type": "press_release", "locator": "Key findings", "quote": "Spending on cell and gene therapies is increasing rapidly and reached $5.9Bn in 2023, up 38% from 2022 although spending accounted for only 0.4% of the $1.6Tn spent on medicines globally in 2023.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2023). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_KZMQKVXHWFTKJV7T310W619CKK", "bibtex": "@misc{iqvia2023cell619ckk,\n author = {{IQVIA Institute}},\n title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_KZMQKVXHWFTKJV7T310W619CKK},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_01M2KJ7XCF5037JCNPDKKT7NNG", "url": "https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNG", "indicator": { "slug": "cell-and-gene-therapy-venture-capital-and-public-funding-deal-count", "name": "Cell and gene therapy venture capital and public funding deal count", "definition": "Number of venture capital and public funding transactions for cell and gene therapies in a given year." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true }, { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": false } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2023-01-01", "end": "2023-12-31", "type": "year" }, "value": 100, "value_text": "nearly 100 deals", "unit": "count", "currency": null, "scale": "1", "value_type": "estimate", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies", "document_type": "press_release", "locator": "Cell and gene therapy venture capital and public funding deal value in U.S.$$Mn and number of deals by type, 2014-2023", "quote": "Following historic funding levels in 2021 and a retraction in 2022, nearly 100 deals and $3.4Bn of deal value occurred in 2023.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2023). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNG", "bibtex": "@misc{iqvia2023cellkt7nng,\n author = {{IQVIA Institute}},\n title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNG},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_01M2KJ7XCF5037JCNPDKKT7NNP", "url": "https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNP", "indicator": { "slug": "cell-and-gene-therapy-venture-capital-and-public-funding-deal-count", "name": "Cell and gene therapy venture capital and public funding deal count", "definition": "Number of venture capital and public funding transactions for cell and gene therapies in a given year." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true }, { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": false } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2023-01-01", "end": "2023-12-31", "type": "year" }, "value": 96, "value_text": "96 deals", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies", "document_type": "press_release", "locator": "Cell and gene therapy venture capital and public funding deal value in U.S.$$Mn and number of deals by type, 2014-2023", "quote": "The total number of deals peaked at 127 in 2021 — 57% higher than in 2020 — dropped 24% in 2022 to 97 deals, and remained flat in 2023 at 96 deals, although still up 19% from 2020.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2023). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNP", "bibtex": "@misc{iqvia2023cellkt7nnp,\n author = {{IQVIA Institute}},\n title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNP},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_01M2KJ7XCF5037JCNPDKKT7NNN", "url": "https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNN", "indicator": { "slug": "cell-and-gene-therapy-venture-capital-and-public-funding-deal-count", "name": "Cell and gene therapy venture capital and public funding deal count", "definition": "Number of venture capital and public funding transactions for cell and gene therapies in a given year." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true }, { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": false } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2022-01-01", "end": "2022-12-31", "type": "year" }, "value": 97, "value_text": "97 deals", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies", "document_type": "press_release", "locator": "Cell and gene therapy venture capital and public funding deal value in U.S.$$Mn and number of deals by type, 2014-2023", "quote": "The total number of deals peaked at 127 in 2021 — 57% higher than in 2020 — dropped 24% in 2022 to 97 deals, and remained flat in 2023 at 96 deals, although still up 19% from 2020.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2022). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNN", "bibtex": "@misc{iqvia2022cellkt7nnn,\n author = {{IQVIA Institute}},\n title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios},\n year = {2022},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNN},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_01M2KJ7XCF5037JCNPDKKT7NNJ", "url": "https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNJ", "indicator": { "slug": "cell-and-gene-therapy-venture-capital-and-public-funding-deal-count", "name": "Cell and gene therapy venture capital and public funding deal count", "definition": "Number of venture capital and public funding transactions for cell and gene therapies in a given year." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true }, { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": false } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2021-01-01", "end": "2021-12-31", "type": "year" }, "value": 127, "value_text": "127", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies", "document_type": "press_release", "locator": "Cell and gene therapy venture capital and public funding deal value in U.S.$$Mn and number of deals by type, 2014-2023", "quote": "The total number of deals peaked at 127 in 2021 — 57% higher than in 2020 — dropped 24% in 2022 to 97 deals, and remained flat in 2023 at 96 deals, although still up 19% from 2020.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2021). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNJ", "bibtex": "@misc{iqvia2021cellkt7nnj,\n author = {{IQVIA Institute}},\n title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios},\n year = {2021},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNJ},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_01M2KJ7XCF5037JCNPDKKT7NNH", "url": "https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNH", "indicator": { "slug": "cell-and-gene-therapy-venture-capital-and-public-funding-deal-value", "name": "Cell and gene therapy venture capital and public funding deal value", "definition": "Total value of venture capital and public funding transactions for cell and gene therapies in a given year." }, "industry": [ { "slug": "pharmaceuticals", "name": "Manufacture of basic pharmaceutical products and pharmaceutical preparations", "isic": "C21", "is_primary": true }, { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": false } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2023-01-01", "end": "2023-12-31", "type": "year" }, "value": 3.4, "value_text": "$3.4Bn", "unit": "USD", "currency": "USD", "scale": "billion", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies", "document_type": "press_release", "locator": "Cell and gene therapy venture capital and public funding deal value in U.S.$$Mn and number of deals by type, 2014-2023", "quote": "Following historic funding levels in 2021 and a retraction in 2022, nearly 100 deals and $3.4Bn of deal value occurred in 2023.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-15T22:15:46.809Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2023). Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Via StatOrigin, https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNH", "bibtex": "@misc{iqvia2023cellkt7nnh,\n author = {{IQVIA Institute}},\n title = {Strengthening Pathways for Cell and Gene Therapies: Current State and Future Scenarios},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_01M2KJ7XCF5037JCNPDKKT7NNH},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/strengthening-pathways-for-cell-and-gene-therapies. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-15T22:15:46.809Z" }, { "id": "stat_B0MJT3FDHN9S5XAPGB6GR93N6C", "url": "https://statorigin.org/stat/stat_B0MJT3FDHN9S5XAPGB6GR93N6C", "indicator": { "slug": "change-in-regional-share-of-global-clinical-trial-country-uses", "name": "Change in regional share of global clinical trial country uses", "definition": "Percentage change in a region's share of global clinical trial country uses between two periods." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "EU", "name": "European Union", "type": "bloc" }, "period": { "start": "2019-01-01", "end": "2025-12-31", "type": "year" }, "value": -17, "value_text": "17%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Global R&D Trends 2026", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2025", "document_type": "press_release", "locator": "Exhibit 55: Country utilization as percentage of global trial country uses, 2019 and 2025", "quote": "Although Western Europe remained the most-utilized region in 2025, with a 27% share of global country uses, its utilization fell by 17% in comparison to 2019.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2025). Global R&D Trends 2026. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2025. Via StatOrigin, https://statorigin.org/stat/stat_B0MJT3FDHN9S5XAPGB6GR93N6C", "bibtex": "@misc{iqvia2025changer93n6c,\n author = {{IQVIA Institute}},\n title = {Global R\\&D Trends 2026},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_B0MJT3FDHN9S5XAPGB6GR93N6C},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-trends-in-r-and-d-2025. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_SQ9DS6RADFJ9ZQ90GXV1Z50C0B", "url": "https://statorigin.org/stat/stat_SQ9DS6RADFJ9ZQ90GXV1Z50C0B", "indicator": { "slug": "change-in-regional-share-of-global-clinical-trial-country-uses", "name": "Change in regional share of global clinical trial country uses", "definition": "Percentage change in a region's share of global clinical trial country uses between two periods." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "EU", "name": "European Union", "type": "bloc" }, "period": { "start": "2019-01-01", "end": "2025-12-31", "type": "year" }, "value": -17, "value_text": "17%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Global R&D Trends 2026", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-r-and-d-trends-2026", "document_type": "press_release", "locator": "Exhibit 55: Country utilization as percentage of global trial country uses, 2019 and 2025", "quote": "Although Western Europe remained the most-utilized region in 2025, with a 27% share of global country uses, its utilization fell by 17% in comparison to 2019.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2025). Global R&D Trends 2026. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-r-and-d-trends-2026. Via StatOrigin, https://statorigin.org/stat/stat_SQ9DS6RADFJ9ZQ90GXV1Z50C0B", "bibtex": "@misc{iqvia2025changez50c0b,\n author = {{IQVIA Institute}},\n title = {Global R\\&D Trends 2026},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_SQ9DS6RADFJ9ZQ90GXV1Z50C0B},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-r-and-d-trends-2026. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_1D4B4KPDFK0WHBM8D327B6EW89", "url": "https://statorigin.org/stat/stat_1D4B4KPDFK0WHBM8D327B6EW89", "indicator": { "slug": "change-in-regional-share-of-global-clinical-trial-country-uses", "name": "Change in regional share of global clinical trial country uses", "definition": "Percentage change in a region's share of global clinical trial country uses between two periods." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "EU", "name": "European Union", "type": "bloc" }, "period": { "start": "2019-01-01", "end": "2023-12-31", "type": "year" }, "value": 21, "value_text": "21%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Rethinking Clinical Trial Country Prioritization", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization", "document_type": "press_release", "locator": "Key findings", "quote": "Country utilization by region has shifted significantly in the past five years with Western Europe share declining by 21% (from 32% to 25% of global total) and Eastern Europe share decreasing 33% (from 17% to 11%), as North America share increased 17% (from 19% to 23%) and China share increased 57% (from 10% to 15%).", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2023). Rethinking Clinical Trial Country Prioritization. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization. Via StatOrigin, https://statorigin.org/stat/stat_1D4B4KPDFK0WHBM8D327B6EW89", "bibtex": "@misc{iqvia2023changeb6ew89,\n author = {{IQVIA Institute}},\n title = {Rethinking Clinical Trial Country Prioritization},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_1D4B4KPDFK0WHBM8D327B6EW89},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_2J0Y2WA7Z6ZFJ8RAPE1DA2HPC9", "url": "https://statorigin.org/stat/stat_2J0Y2WA7Z6ZFJ8RAPE1DA2HPC9", "indicator": { "slug": "change-in-regional-share-of-global-clinical-trial-country-uses", "name": "Change in regional share of global clinical trial country uses", "definition": "Percentage change in a region's share of global clinical trial country uses between two periods." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "NAMERICA", "name": "North America", "type": "bloc" }, "period": { "start": "2019-01-01", "end": "2023-12-31", "type": "year" }, "value": 17, "value_text": "17%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Rethinking Clinical Trial Country Prioritization", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization", "document_type": "press_release", "locator": "Key findings", "quote": "Country utilization by region has shifted significantly in the past five years with Western Europe share declining by 21% (from 32% to 25% of global total) and Eastern Europe share decreasing 33% (from 17% to 11%), as North America share increased 17% (from 19% to 23%) and China share increased 57% (from 10% to 15%).", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2023). Rethinking Clinical Trial Country Prioritization. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization. Via StatOrigin, https://statorigin.org/stat/stat_2J0Y2WA7Z6ZFJ8RAPE1DA2HPC9", "bibtex": "@misc{iqvia2023changea2hpc9,\n author = {{IQVIA Institute}},\n title = {Rethinking Clinical Trial Country Prioritization},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_2J0Y2WA7Z6ZFJ8RAPE1DA2HPC9},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_1AFNYY5PNGTNY3YMMFH8ANZV62", "url": "https://statorigin.org/stat/stat_1AFNYY5PNGTNY3YMMFH8ANZV62", "indicator": { "slug": "change-in-regional-share-of-global-clinical-trial-country-uses", "name": "Change in regional share of global clinical trial country uses", "definition": "Percentage change in a region's share of global clinical trial country uses between two periods." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2019-01-01", "end": "2023-12-31", "type": "year" }, "value": 57, "value_text": "57%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Rethinking Clinical Trial Country Prioritization", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization", "document_type": "press_release", "locator": "Key findings", "quote": "Country utilization by region has shifted significantly in the past five years with Western Europe share declining by 21% (from 32% to 25% of global total) and Eastern Europe share decreasing 33% (from 17% to 11%), as North America share increased 17% (from 19% to 23%) and China share increased 57% (from 10% to 15%).", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2023). Rethinking Clinical Trial Country Prioritization. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization. Via StatOrigin, https://statorigin.org/stat/stat_1AFNYY5PNGTNY3YMMFH8ANZV62", "bibtex": "@misc{iqvia2023changeanzv62,\n author = {{IQVIA Institute}},\n title = {Rethinking Clinical Trial Country Prioritization},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_1AFNYY5PNGTNY3YMMFH8ANZV62},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/rethinking-clinical-trial-country-prioritization. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_K9M5MYSB5X6DW145DPM1A10NZS", "url": "https://statorigin.org/stat/stat_K9M5MYSB5X6DW145DPM1A10NZS", "indicator": { "slug": "childhood-cancer-incidence", "name": "Childhood cancer incidence", "definition": "The estimated number of children who develop cancer each year." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2026-01-01", "end": "2026-12-31", "type": "year" }, "value": 400000, "value_text": "400 000", "unit": "count", "currency": null, "scale": "1", "value_type": "estimate", "source": { "org": "World Health Organization", "org_short_name": "WHO", "org_url": "https://www.who.int", "org_tier": 1, "document_title": "New strategy to build a healthier market for childhood cancer medicines", "document_url": "https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines", "document_type": "press_release", "locator": "New strategy to build a healthier market for childhood cancer medicines", "quote": "Each year, an estimated 400 000 children develop cancer.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "World Health Organization. (2026). New strategy to build a healthier market for childhood cancer medicines. Retrieved September 16, 2026, from https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines. Via StatOrigin, https://statorigin.org/stat/stat_K9M5MYSB5X6DW145DPM1A10NZS", "bibtex": "@misc{who2026childhooda10nzs,\n author = {{World Health Organization}},\n title = {New strategy to build a healthier market for childhood cancer medicines},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_K9M5MYSB5X6DW145DPM1A10NZS},\n note = {Original source: https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_7VHCQ6Q2V01J0CQ9EKA7R3ZH1W", "url": "https://statorigin.org/stat/stat_7VHCQ6Q2V01J0CQ9EKA7R3ZH1W", "indicator": { "slug": "childhood-cancer-medicines-lacking-child-friendly-formulations", "name": "Childhood cancer medicines lacking child-friendly formulations", "definition": "The number of medicines with established paediatric indications but without suitable child-friendly formulations, identified at the paediatric drug optimization exercise." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2024-01-01", "end": "2024-01-31", "type": "point" }, "value": 6, "value_text": "Six", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "World Health Organization", "org_short_name": "WHO", "org_url": "https://www.who.int", "org_tier": 1, "document_title": "WHO advances access to quality-assured, child-friendly cancer medicines", "document_url": "https://www.who.int/news/item/04-09-2026-who-advances-access-to-quality-assured--child-friendly-cancer-medicines", "document_type": "press_release", "locator": "From identifying needs to stimulating product development", "quote": "Six medicines with established paediatric indications but without suitable child-friendly formulations were noted: cyclophosphamide, etoposide, mercaptopurine, methotrexate, procarbazine and temozolomide.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "World Health Organization. (2024). WHO advances access to quality-assured, child-friendly cancer medicines. Retrieved September 16, 2026, from https://www.who.int/news/item/04-09-2026-who-advances-access-to-quality-assured--child-friendly-cancer-medicines. Via StatOrigin, https://statorigin.org/stat/stat_7VHCQ6Q2V01J0CQ9EKA7R3ZH1W", "bibtex": "@misc{who2024childhoodr3zh1w,\n author = {{World Health Organization}},\n title = {WHO advances access to quality-assured, child-friendly cancer medicines},\n year = {2024},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_7VHCQ6Q2V01J0CQ9EKA7R3ZH1W},\n note = {Original source: https://www.who.int/news/item/04-09-2026-who-advances-access-to-quality-assured--child-friendly-cancer-medicines. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_0ZN6HK2VP8CD4DNEMD29W75C86", "url": "https://statorigin.org/stat/stat_0ZN6HK2VP8CD4DNEMD29W75C86", "indicator": { "slug": "commercial-insurance-out-of-pocket-cost-growth", "name": "Commercial insurance out-of-pocket cost growth", "definition": "Year-over-year aggregate percentage growth in commercial insurance patient out-of-pocket medicine costs." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "US", "name": "United States", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 5, "value_text": "5%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "U.S. Medicine Use Trends 2026", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/us-medicine-use-trends-2026", "document_type": "press_release", "locator": "Other Findings", "quote": "Commercial insurance out‑of‑pocket costs, which account for 52% of total patient out‑of‑pocket costs, rose 5% in aggregate in 2025 and 37% over five years due to increased volume and a shift towards higher‑cost prescriptions.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2025). U.S. Medicine Use Trends 2026. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/us-medicine-use-trends-2026. Via StatOrigin, https://statorigin.org/stat/stat_0ZN6HK2VP8CD4DNEMD29W75C86", "bibtex": "@misc{iqvia2025commercialw75c86,\n author = {{IQVIA Institute}},\n title = {U.S. Medicine Use Trends 2026},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_0ZN6HK2VP8CD4DNEMD29W75C86},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/us-medicine-use-trends-2026. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_JNV9T4G7XKM6JDNTGS7TE1BNKD", "url": "https://statorigin.org/stat/stat_JNV9T4G7XKM6JDNTGS7TE1BNKD", "indicator": { "slug": "commercial-insurance-out-of-pocket-cost-growth-5-year", "name": "Commercial insurance out-of-pocket cost growth (5-year)", "definition": "Aggregate percentage growth in commercial insurance patient out-of-pocket medicine costs over the preceding five years." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "US", "name": "United States", "type": "country" }, "period": { "start": "2021-01-01", "end": "2025-12-31", "type": "year" }, "value": 37, "value_text": "37%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "U.S. Medicine Use Trends 2026", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/us-medicine-use-trends-2026", "document_type": "press_release", "locator": "Other Findings", "quote": "Commercial insurance out‑of‑pocket costs, which account for 52% of total patient out‑of‑pocket costs, rose 5% in aggregate in 2025 and 37% over five years due to increased volume and a shift towards higher‑cost prescriptions.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2025). U.S. Medicine Use Trends 2026. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/us-medicine-use-trends-2026. Via StatOrigin, https://statorigin.org/stat/stat_JNV9T4G7XKM6JDNTGS7TE1BNKD", "bibtex": "@misc{iqvia2025commerciale1bnkd,\n author = {{IQVIA Institute}},\n title = {U.S. Medicine Use Trends 2026},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_JNV9T4G7XKM6JDNTGS7TE1BNKD},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/us-medicine-use-trends-2026. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_SXCAHHYCQ12XXT8NCDXKATWBAT", "url": "https://statorigin.org/stat/stat_SXCAHHYCQ12XXT8NCDXKATWBAT", "indicator": { "slug": "commercial-insurance-share-of-patient-out-of-pocket-costs", "name": "Commercial insurance share of patient out-of-pocket costs", "definition": "Share of total patient out-of-pocket medicine costs attributable to commercially insured patients." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "US", "name": "United States", "type": "country" }, "period": { "start": "2025-01-01", "end": "2025-12-31", "type": "year" }, "value": 52, "value_text": "52%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "U.S. Medicine Use Trends 2026", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/us-medicine-use-trends-2026", "document_type": "press_release", "locator": "Other Findings", "quote": "Commercial insurance out‑of‑pocket costs, which account for 52% of total patient out‑of‑pocket costs, rose 5% in aggregate in 2025 and 37% over five years due to increased volume and a shift towards higher‑cost prescriptions.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2025). U.S. Medicine Use Trends 2026. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/us-medicine-use-trends-2026. Via StatOrigin, https://statorigin.org/stat/stat_SXCAHHYCQ12XXT8NCDXKATWBAT", "bibtex": "@misc{iqvia2025commercialatwbat,\n author = {{IQVIA Institute}},\n title = {U.S. Medicine Use Trends 2026},\n year = {2025},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_SXCAHHYCQ12XXT8NCDXKATWBAT},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/us-medicine-use-trends-2026. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_RA1PH1KQTKGZAGX5BDGPRFDSMP", "url": "https://statorigin.org/stat/stat_RA1PH1KQTKGZAGX5BDGPRFDSMP", "indicator": { "slug": "countries-excluding-u-s-driving-global-pharmaceutical-spending-growth", "name": "Countries (excluding U.S.) driving global pharmaceutical spending growth", "definition": "Number of countries, other than the U.S., accounting for the majority of global pharmaceutical spending growth through 2030." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2025-01-01", "end": "2030-12-31", "type": "year" }, "value": 14, "value_text": "14 other countries", "unit": "count", "currency": null, "scale": "1", "value_type": "forecast", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Global Medicine Use Trends 2026", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-medicine-use-trends-2026", "document_type": "press_release", "locator": "Exhibit 19: Global spending and growth, excluding COVID-19 vaccines and therapeutics,constant $USBn, 2020–2030", "quote": "The U.S. and 14 other countries account for 76% of global growth through 2030.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2030). Global Medicine Use Trends 2026. Retrieved September 15, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-medicine-use-trends-2026. Via StatOrigin, https://statorigin.org/stat/stat_RA1PH1KQTKGZAGX5BDGPRFDSMP", "bibtex": "@misc{iqvia2030countriesrfdsmp,\n author = {{IQVIA Institute}},\n title = {Global Medicine Use Trends 2026},\n year = {2030},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_RA1PH1KQTKGZAGX5BDGPRFDSMP},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-medicine-use-trends-2026. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_WHJ9R2JH2WSB7MBQ2VB2PKTEJ8", "url": "https://statorigin.org/stat/stat_WHJ9R2JH2WSB7MBQ2VB2PKTEJ8", "indicator": { "slug": "domestic-only-oncology-nas-launches-cumulative", "name": "Domestic-only oncology NAS launches (cumulative)", "definition": "Number of oncology novel active substances launched only in their domestic market, with no launch in other markets, over a stated period." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2020-01-01", "end": "2024-12-31", "type": "year" }, "value": 45, "value_text": "45", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "IQVIA Institute", "org_short_name": "IQVIA", "org_url": "https://www.iqvia.com", "org_tier": 3, "document_title": "Global Oncology Trends 2025", "document_url": "https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025", "document_type": "press_release", "locator": "Other Findings", "quote": "Notably, China had 45 NAS in the past five years that have not launched in other markets to date, beginning a pattern of domestic-first or domestic-only innovation not previously seen.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "IQVIA Institute. (2024). Global Oncology Trends 2025. Retrieved September 16, 2026, from https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Via StatOrigin, https://statorigin.org/stat/stat_WHJ9R2JH2WSB7MBQ2VB2PKTEJ8", "bibtex": "@misc{iqvia2024domesticpktej8,\n author = {{IQVIA Institute}},\n title = {Global Oncology Trends 2025},\n year = {2024},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_WHJ9R2JH2WSB7MBQ2VB2PKTEJ8},\n note = {Original source: https://www.iqvia.com/insights/the-iqvia-institute/reports-and-publications/reports/global-oncology-trends-2025. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_PQR0W5XRX8JHY4A05NEK4DZHJW", "url": "https://statorigin.org/stat/stat_PQR0W5XRX8JHY4A05NEK4DZHJW", "indicator": { "slug": "drug-overdose-deaths", "name": "Drug overdose deaths", "definition": "The predicted number of drug overdose deaths in the United States over a rolling 12-month period, based on provisional CDC surveillance data." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "US", "name": "United States", "type": "country" }, "period": { "start": "2025-04-01", "end": "2026-03-31", "type": "year" }, "value": 67798, "value_text": "67,798", "unit": "count", "currency": null, "scale": "1", "value_type": "estimate", "source": { "org": "Centers for Disease Control and Prevention", "org_short_name": "CDC", "org_url": "https://www.cdc.gov", "org_tier": 1, "document_title": "CDC Launches New Overdose Prevention Data Channel", "document_url": "https://www.cdc.gov/media/releases/2026/cdc-launches-new-overdose-prevention-data-channel.html", "document_type": "press_release", "locator": "RELEASE", "quote": "The launch comes as the latest monthly provisional data from CDC's National Vital Statistics System (NVSS) predicts 67,798 drug overdose deaths in the United States during the 12 months ending in March 2026.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "Centers for Disease Control and Prevention. (2026). CDC Launches New Overdose Prevention Data Channel. Retrieved September 16, 2026, from https://www.cdc.gov/media/releases/2026/cdc-launches-new-overdose-prevention-data-channel.html. Via StatOrigin, https://statorigin.org/stat/stat_PQR0W5XRX8JHY4A05NEK4DZHJW", "bibtex": "@misc{cdc2026drug4dzhjw,\n author = {{Centers for Disease Control and Prevention}},\n title = {CDC Launches New Overdose Prevention Data Channel},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_PQR0W5XRX8JHY4A05NEK4DZHJW},\n note = {Original source: https://www.cdc.gov/media/releases/2026/cdc-launches-new-overdose-prevention-data-channel.html. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_H7WZ5JHD1YFSWDWJ8YA36S4PKJ", "url": "https://statorigin.org/stat/stat_H7WZ5JHD1YFSWDWJ8YA36S4PKJ", "indicator": { "slug": "drug-overdose-deaths-year-over-year-change", "name": "Drug overdose deaths year-over-year change", "definition": "The percentage decrease in predicted drug overdose deaths compared to the same 12-month period one year earlier." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "US", "name": "United States", "type": "country" }, "period": { "start": "2025-04-01", "end": "2026-03-31", "type": "year" }, "value": -12.3, "value_text": "12.3%", "unit": "percent", "currency": null, "scale": "1", "value_type": "estimate", "source": { "org": "Centers for Disease Control and Prevention", "org_short_name": "CDC", "org_url": "https://www.cdc.gov", "org_tier": 1, "document_title": "CDC Launches New Overdose Prevention Data Channel", "document_url": "https://www.cdc.gov/media/releases/2026/cdc-launches-new-overdose-prevention-data-channel.html", "document_type": "press_release", "locator": "RELEASE", "quote": "This is a 12.3% decrease in overdose deaths compared to the same time period in the previous year.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "Centers for Disease Control and Prevention. (2026). CDC Launches New Overdose Prevention Data Channel. Retrieved September 16, 2026, from https://www.cdc.gov/media/releases/2026/cdc-launches-new-overdose-prevention-data-channel.html. Via StatOrigin, https://statorigin.org/stat/stat_H7WZ5JHD1YFSWDWJ8YA36S4PKJ", "bibtex": "@misc{cdc2026drug6s4pkj,\n author = {{Centers for Disease Control and Prevention}},\n title = {CDC Launches New Overdose Prevention Data Channel},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_H7WZ5JHD1YFSWDWJ8YA36S4PKJ},\n note = {Original source: https://www.cdc.gov/media/releases/2026/cdc-launches-new-overdose-prevention-data-channel.html. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_9JCGMDR9A7EGMWZHBRZ3D7Y4QF", "url": "https://statorigin.org/stat/stat_9JCGMDR9A7EGMWZHBRZ3D7Y4QF", "indicator": { "slug": "global-initiative-for-childhood-cancer-beneficiaries", "name": "Global Initiative for Childhood Cancer beneficiaries", "definition": "Cumulative number of children who have benefited from strengthened cancer care systems since the Global Initiative for Childhood Cancer launched in 2018." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2018-01-01", "end": "2026-09-15", "type": "point" }, "value": 500000, "value_text": "nearly 500 000", "unit": "count", "currency": null, "scale": "1", "value_type": "estimate", "source": { "org": "World Health Organization", "org_short_name": "WHO", "org_url": "https://www.who.int", "org_tier": 1, "document_title": "New strategy to build a healthier market for childhood cancer medicines", "document_url": "https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines", "document_type": "press_release", "locator": "New strategy to build a healthier market for childhood cancer medicines", "quote": "Since WHO and partners launched the Global Initiative for Childhood Cancer in 2018, nearly 500 000 children in 90 countries have benefited from strengthened systems to provide care and address inequalities.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "World Health Organization. (2026). New strategy to build a healthier market for childhood cancer medicines. Retrieved September 16, 2026, from https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines. Via StatOrigin, https://statorigin.org/stat/stat_9JCGMDR9A7EGMWZHBRZ3D7Y4QF", "bibtex": "@misc{who2026initiatived7y4qf,\n author = {{World Health Organization}},\n title = {New strategy to build a healthier market for childhood cancer medicines},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_9JCGMDR9A7EGMWZHBRZ3D7Y4QF},\n note = {Original source: https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_YP7VSNBWC4HH67A66WACBTZ352", "url": "https://statorigin.org/stat/stat_YP7VSNBWC4HH67A66WACBTZ352", "indicator": { "slug": "global-initiative-for-childhood-cancer-country-coverage", "name": "Global Initiative for Childhood Cancer country coverage", "definition": "Number of countries in which children have benefited from strengthened cancer care systems under the Global Initiative for Childhood Cancer since 2018." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2018-01-01", "end": "2026-09-15", "type": "point" }, "value": 90, "value_text": "90 countries", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "World Health Organization", "org_short_name": "WHO", "org_url": "https://www.who.int", "org_tier": 1, "document_title": "New strategy to build a healthier market for childhood cancer medicines", "document_url": "https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines", "document_type": "press_release", "locator": "New strategy to build a healthier market for childhood cancer medicines", "quote": "Since WHO and partners launched the Global Initiative for Childhood Cancer in 2018, nearly 500 000 children in 90 countries have benefited from strengthened systems to provide care and address inequalities.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "World Health Organization. (2026). New strategy to build a healthier market for childhood cancer medicines. Retrieved September 16, 2026, from https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines. Via StatOrigin, https://statorigin.org/stat/stat_YP7VSNBWC4HH67A66WACBTZ352", "bibtex": "@misc{who2026initiativebtz352,\n author = {{World Health Organization}},\n title = {New strategy to build a healthier market for childhood cancer medicines},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_YP7VSNBWC4HH67A66WACBTZ352},\n note = {Original source: https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_DVNDHTM0TJP8PMNCPJ2JYGGWV3", "url": "https://statorigin.org/stat/stat_DVNDHTM0TJP8PMNCPJ2JYGGWV3", "indicator": { "slug": "global-platform-participating-countries", "name": "Global Platform participating countries", "definition": "Number of participating countries the Global Platform for Access to Childhood Cancer Medicines has been working with since 2024." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2024-01-01", "end": "2026-09-15", "type": "point" }, "value": 12, "value_text": "12", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "World Health Organization", "org_short_name": "WHO", "org_url": "https://www.who.int", "org_tier": 1, "document_title": "New strategy to build a healthier market for childhood cancer medicines", "document_url": "https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines", "document_type": "press_release", "locator": "Note to the editor", "quote": "The Global Platform has been working with 12 participating countries since 2024: Ecuador, El Salvador, Ghana, Jordan, Moldova, Mongolia, Nepal, Pakistan, Senegal, Sri Lanka, Uzbekistan and Zambia.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "World Health Organization. (2026). New strategy to build a healthier market for childhood cancer medicines. Retrieved September 16, 2026, from https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines. Via StatOrigin, https://statorigin.org/stat/stat_DVNDHTM0TJP8PMNCPJ2JYGGWV3", "bibtex": "@misc{who2026platformyggwv3,\n author = {{World Health Organization}},\n title = {New strategy to build a healthier market for childhood cancer medicines},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_DVNDHTM0TJP8PMNCPJ2JYGGWV3},\n note = {Original source: https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_VZ92KGJPZVP4C12NGRTKTBHVEH", "url": "https://statorigin.org/stat/stat_VZ92KGJPZVP4C12NGRTKTBHVEH", "indicator": { "slug": "global-platform-participating-governments", "name": "Global Platform participating governments", "definition": "Number of governments the Global Platform for Access to Childhood Cancer Medicines is working with to create a more predictable and sustainable market." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2026-09-15", "end": "2026-09-15", "type": "point" }, "value": 12, "value_text": "twelve", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "World Health Organization", "org_short_name": "WHO", "org_url": "https://www.who.int", "org_tier": 1, "document_title": "New strategy to build a healthier market for childhood cancer medicines", "document_url": "https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines", "document_type": "press_release", "locator": "Implementing the foundations of the strategy", "quote": "The Global Platform is also working with twelve governments to create a more predictable and sustainable market, with additional ones to follow soon.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "World Health Organization. (2026). New strategy to build a healthier market for childhood cancer medicines. Retrieved September 16, 2026, from https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines. Via StatOrigin, https://statorigin.org/stat/stat_VZ92KGJPZVP4C12NGRTKTBHVEH", "bibtex": "@misc{who2026platformtbhveh,\n author = {{World Health Organization}},\n title = {New strategy to build a healthier market for childhood cancer medicines},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_VZ92KGJPZVP4C12NGRTKTBHVEH},\n note = {Original source: https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_0ZPYA5R82ZPAYC8095D7N05GF8", "url": "https://statorigin.org/stat/stat_0ZPYA5R82ZPAYC8095D7N05GF8", "indicator": { "slug": "health-and-social-services-investment-growth-rate", "name": "Health and social services investment growth rate", "definition": "Year-on-year growth rate of fixed-asset investment in the health and social services sector." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2026-01-01", "end": "2026-07-31", "type": "month" }, "value": -13, "value_text": "-13.0", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "National Bureau of Statistics of China", "org_short_name": "NBS China", "org_url": "https://www.stats.gov.cn", "org_tier": 1, "document_title": "Investment in Fixed Assets from January to July 2026", "document_url": "https://www.stats.gov.cn/english/PressRelease/202608/t20260818_1965072.html", "document_type": "press_release", "locator": "Table: Investment in Fixed Assets (Excluding Rural Households) from January to July 2026", "quote": "Health and social services -13.0", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "National Bureau of Statistics of China. (2026). Investment in Fixed Assets from January to July 2026. Retrieved September 15, 2026, from https://www.stats.gov.cn/english/PressRelease/202608/t20260818_1965072.html. Via StatOrigin, https://statorigin.org/stat/stat_0ZPYA5R82ZPAYC8095D7N05GF8", "bibtex": "@misc{nbschina2026healthn05gf8,\n author = {{National Bureau of Statistics of China}},\n title = {Investment in Fixed Assets from January to July 2026},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_0ZPYA5R82ZPAYC8095D7N05GF8},\n note = {Original source: https://www.stats.gov.cn/english/PressRelease/202608/t20260818\\_1965072.html. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_NR3QFBCKX5CBQGBP6MBRDGAJMX", "url": "https://statorigin.org/stat/stat_NR3QFBCKX5CBQGBP6MBRDGAJMX", "indicator": { "slug": "health-care-and-medical-services-price-index-growth-rate", "name": "Health care and medical services price index growth rate", "definition": "Year-on-year percentage change in the Consumer Price Index subcategory for health care and medical services." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2026-08-01", "end": "2026-08-31", "type": "month" }, "value": 2.7, "value_text": "2.7%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "National Bureau of Statistics of China", "org_short_name": "NBS China", "org_url": "https://www.stats.gov.cn", "org_tier": 1, "document_title": "Consumer Price Index in August 2026", "document_url": "https://www.stats.gov.cn/english/PressRelease/202609/t20260910_1965275.html", "document_type": "press_release", "locator": "I. Year-on-Year Changes in Price Indexes for Various Goods and Services", "quote": "Specifically, the price indexes for miscellaneous goods and services, health care and medical services, and transportation and telecommunication increased by 7.3%, 2.7% and 2.5%, respectively; the price indexes for education, culture and recreation, clothing and household facilities, articles and services increased by 1.4%, 1.3% and 0.7%, respectively; and the price index for residence decreased by 0.3%.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "National Bureau of Statistics of China. (2026). Consumer Price Index in August 2026. Retrieved September 16, 2026, from https://www.stats.gov.cn/english/PressRelease/202609/t20260910_1965275.html. Via StatOrigin, https://statorigin.org/stat/stat_NR3QFBCKX5CBQGBP6MBRDGAJMX", "bibtex": "@misc{nbschina2026healthdgajmx,\n author = {{National Bureau of Statistics of China}},\n title = {Consumer Price Index in August 2026},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_NR3QFBCKX5CBQGBP6MBRDGAJMX},\n note = {Original source: https://www.stats.gov.cn/english/PressRelease/202609/t20260910\\_1965275.html. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_1RSMVYNHFQ11Q10W85F8RPRZB7", "url": "https://statorigin.org/stat/stat_1RSMVYNHFQ11Q10W85F8RPRZB7", "indicator": { "slug": "health-care-and-medical-services-price-index-growth-rate", "name": "Health care and medical services price index growth rate", "definition": "Year-on-year percentage change in the Consumer Price Index subcategory for health care and medical services." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2026-08-01", "end": "2026-08-31", "type": "month" }, "value": 2.7, "value_text": "2.7 percent", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "National Bureau of Statistics of China", "org_short_name": "NBS China", "org_url": "https://www.stats.gov.cn", "org_tier": 1, "document_title": "National Economy Remained Steady with Innovation-Led and High-Quality Development in August", "document_url": "https://www.stats.gov.cn/english/PressRelease/202609/t20260915_1965305.html", "document_type": "press_release", "locator": "7. Consumer Price Rose Mildly and Producer Prices for Industrial Products Grew Faster Year on Year.", "quote": "Grouped by commodity categories, prices for food, tobacco, alcohol and dining out went down by 0.7 percent year on year; clothing up by 1.3 percent; housing down by 0.3 percent; articles and services for daily use up by 0.7 percent; transportation and communication up by 2.5 percent; education, culture and recreation up by 1.4 percent; medical services and health care up by 2.7 percent; and other articles and services up by 7.3 percent.", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "National Bureau of Statistics of China. (2026). National Economy Remained Steady with Innovation-Led and High-Quality Development in August. Retrieved September 15, 2026, from https://www.stats.gov.cn/english/PressRelease/202609/t20260915_1965305.html. Via StatOrigin, https://statorigin.org/stat/stat_1RSMVYNHFQ11Q10W85F8RPRZB7", "bibtex": "@misc{nbschina2026healthrprzb7,\n author = {{National Bureau of Statistics of China}},\n title = {National Economy Remained Steady with Innovation-Led and High-Quality Development in August},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_1RSMVYNHFQ11Q10W85F8RPRZB7},\n note = {Original source: https://www.stats.gov.cn/english/PressRelease/202609/t20260915\\_1965305.html. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_M4B6Y2DAGYV2BTY50ZQEFTY4NB", "url": "https://statorigin.org/stat/stat_M4B6Y2DAGYV2BTY50ZQEFTY4NB", "indicator": { "slug": "health-care-and-medical-services-price-index-growth-rate", "name": "Health care and medical services price index growth rate", "definition": "Year-on-year percentage change in the Consumer Price Index subcategory for health care and medical services." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2026-01-01", "end": "2026-08-31", "type": "point" }, "value": 2.2, "value_text": "2.2", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "National Bureau of Statistics of China", "org_short_name": "NBS China", "org_url": "https://www.stats.gov.cn", "org_tier": 1, "document_title": "Consumer Price Index in August 2026", "document_url": "https://www.stats.gov.cn/english/PressRelease/202609/t20260910_1965275.html", "document_type": "press_release", "locator": "Consumer Price Indexes in August 2026", "quote": "VII. Health care and medical services 0.0 2.7 2.2", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "National Bureau of Statistics of China. (2026). Consumer Price Index in August 2026. Retrieved September 16, 2026, from https://www.stats.gov.cn/english/PressRelease/202609/t20260910_1965275.html. Via StatOrigin, https://statorigin.org/stat/stat_M4B6Y2DAGYV2BTY50ZQEFTY4NB", "bibtex": "@misc{nbschina2026healthfty4nb,\n author = {{National Bureau of Statistics of China}},\n title = {Consumer Price Index in August 2026},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_M4B6Y2DAGYV2BTY50ZQEFTY4NB},\n note = {Original source: https://www.stats.gov.cn/english/PressRelease/202609/t20260910\\_1965275.html. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_H4VECD20Q1P73B91KZC815GAHH", "url": "https://statorigin.org/stat/stat_H4VECD20Q1P73B91KZC815GAHH", "indicator": { "slug": "healthcare-expenditure", "name": "Healthcare expenditure", "definition": "Total spending on healthcare, covering public and private sources." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GB", "name": "United Kingdom", "type": "country" }, "period": { "start": "2023-01-01", "end": "2023-12-31", "type": "year" }, "value": 292, "value_text": "£292 billion", "unit": "GBP", "currency": "GBP", "scale": "billion", "value_type": "estimate", "source": { "org": "Office for National Statistics", "org_short_name": "ONS", "org_url": "https://www.ons.gov.uk", "org_tier": 1, "document_title": "Health care system", "document_url": "https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem", "document_type": "press_release", "locator": "Spotlight: Healthcare expenditure, UK Health Accounts: 2022 and 2023", "quote": "Our provisional estimates are that UK healthcare expenditure was around £292 billion in 2023; these are based on more timely but less comprehensive data sources than preceding years.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "Office for National Statistics. (2023). Health care system. Retrieved September 16, 2026, from https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem. Via StatOrigin, https://statorigin.org/stat/stat_H4VECD20Q1P73B91KZC815GAHH", "bibtex": "@misc{ons2023healthcare15gahh,\n author = {{Office for National Statistics}},\n title = {Health care system},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_H4VECD20Q1P73B91KZC815GAHH},\n note = {Original source: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_WTVZV7JEETPWJC0CF28MZAMB3D", "url": "https://statorigin.org/stat/stat_WTVZV7JEETPWJC0CF28MZAMB3D", "indicator": { "slug": "healthcare-expenditure-as-share-of-gdp", "name": "Healthcare expenditure as share of GDP", "definition": "Healthcare expenditure expressed as a percentage of gross domestic product." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GB", "name": "United Kingdom", "type": "country" }, "period": { "start": "2023-01-01", "end": "2023-12-31", "type": "year" }, "value": 10.9, "value_text": "10.9%", "unit": "percent", "currency": null, "scale": "1", "value_type": "estimate", "source": { "org": "Office for National Statistics", "org_short_name": "ONS", "org_url": "https://www.ons.gov.uk", "org_tier": 1, "document_title": "Health care system", "document_url": "https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem", "document_type": "press_release", "locator": "Spotlight: Healthcare expenditure, UK Health Accounts: 2022 and 2023", "quote": "Healthcare spending as a share of gross domestic product (GDP) decreased slightly to 10.9% in 2023 from 11.1% in 2022, as GDP growth exceeded healthcare spending growth.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "Office for National Statistics. (2023). Health care system. Retrieved September 16, 2026, from https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem. Via StatOrigin, https://statorigin.org/stat/stat_WTVZV7JEETPWJC0CF28MZAMB3D", "bibtex": "@misc{ons2023healthcarezamb3d,\n author = {{Office for National Statistics}},\n title = {Health care system},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_WTVZV7JEETPWJC0CF28MZAMB3D},\n note = {Original source: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_P7W195SZHA1C1CK3D0SQ9CKC4J", "url": "https://statorigin.org/stat/stat_P7W195SZHA1C1CK3D0SQ9CKC4J", "indicator": { "slug": "healthcare-expenditure-as-share-of-gdp", "name": "Healthcare expenditure as share of GDP", "definition": "Healthcare expenditure expressed as a percentage of gross domestic product." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GB", "name": "United Kingdom", "type": "country" }, "period": { "start": "2022-01-01", "end": "2022-12-31", "type": "year" }, "value": 11.1, "value_text": "11.1%", "unit": "percent", "currency": null, "scale": "1", "value_type": "estimate", "source": { "org": "Office for National Statistics", "org_short_name": "ONS", "org_url": "https://www.ons.gov.uk", "org_tier": 1, "document_title": "Health care system", "document_url": "https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem", "document_type": "press_release", "locator": "Spotlight: Healthcare expenditure, UK Health Accounts: 2022 and 2023", "quote": "Healthcare spending as a share of gross domestic product (GDP) decreased slightly to 10.9% in 2023 from 11.1% in 2022, as GDP growth exceeded healthcare spending growth.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "Office for National Statistics. (2022). Health care system. Retrieved September 16, 2026, from https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem. Via StatOrigin, https://statorigin.org/stat/stat_P7W195SZHA1C1CK3D0SQ9CKC4J", "bibtex": "@misc{ons2022healthcare9ckc4j,\n author = {{Office for National Statistics}},\n title = {Health care system},\n year = {2022},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_P7W195SZHA1C1CK3D0SQ9CKC4J},\n note = {Original source: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_12JE8SDBY011ZSVTXGSWKJZXF6", "url": "https://statorigin.org/stat/stat_12JE8SDBY011ZSVTXGSWKJZXF6", "indicator": { "slug": "healthcare-expenditure-growth-nominal", "name": "Healthcare expenditure growth, nominal", "definition": "Year-on-year percentage change in total healthcare expenditure in nominal (current price) terms." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GB", "name": "United Kingdom", "type": "country" }, "period": { "start": "2023-01-01", "end": "2023-12-31", "type": "year" }, "value": 5.6, "value_text": "5.6%", "unit": "percent", "currency": null, "scale": "1", "value_type": "estimate", "source": { "org": "Office for National Statistics", "org_short_name": "ONS", "org_url": "https://www.ons.gov.uk", "org_tier": 1, "document_title": "Health care system", "document_url": "https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem", "document_type": "press_release", "locator": "Spotlight: Healthcare expenditure, UK Health Accounts: 2022 and 2023", "quote": "Total healthcare expenditure increased by 5.6% in nominal terms in 2023, but decreased by 1.4% after adjusting for inflation.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "Office for National Statistics. (2023). Health care system. Retrieved September 16, 2026, from https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem. Via StatOrigin, https://statorigin.org/stat/stat_12JE8SDBY011ZSVTXGSWKJZXF6", "bibtex": "@misc{ons2023healthcarekjzxf6,\n author = {{Office for National Statistics}},\n title = {Health care system},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_12JE8SDBY011ZSVTXGSWKJZXF6},\n note = {Original source: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_4FBYWPBR5VW0P33TN52A4VEKQQ", "url": "https://statorigin.org/stat/stat_4FBYWPBR5VW0P33TN52A4VEKQQ", "indicator": { "slug": "healthcare-expenditure-growth-real", "name": "Healthcare expenditure growth, real", "definition": "Year-on-year percentage change in total healthcare expenditure after adjusting for inflation." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GB", "name": "United Kingdom", "type": "country" }, "period": { "start": "2023-01-01", "end": "2023-12-31", "type": "year" }, "value": -1.4, "value_text": "1.4%", "unit": "percent", "currency": null, "scale": "1", "value_type": "estimate", "source": { "org": "Office for National Statistics", "org_short_name": "ONS", "org_url": "https://www.ons.gov.uk", "org_tier": 1, "document_title": "Health care system", "document_url": "https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem", "document_type": "press_release", "locator": "Spotlight: Healthcare expenditure, UK Health Accounts: 2022 and 2023", "quote": "Total healthcare expenditure increased by 5.6% in nominal terms in 2023, but decreased by 1.4% after adjusting for inflation.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "Office for National Statistics. (2023). Health care system. Retrieved September 16, 2026, from https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem. Via StatOrigin, https://statorigin.org/stat/stat_4FBYWPBR5VW0P33TN52A4VEKQQ", "bibtex": "@misc{ons2023healthcare4vekqq,\n author = {{Office for National Statistics}},\n title = {Health care system},\n year = {2023},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_4FBYWPBR5VW0P33TN52A4VEKQQ},\n note = {Original source: https://www.ons.gov.uk/peoplepopulationandcommunity/healthandsocialcare/healthcaresystem. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_D5KJDM50FGMCBZ224977H5YHBE", "url": "https://statorigin.org/stat/stat_D5KJDM50FGMCBZ224977H5YHBE", "indicator": { "slug": "hospitals-receiving-medicare-ipps-payments", "name": "Hospitals receiving Medicare IPPS payments", "definition": "Number of hospitals that receive payments under the Medicare Inpatient Prospective Payment System." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "US", "name": "United States", "type": "country" }, "period": { "start": "2011-01-01", "end": "2012-12-31", "type": "year" }, "value": 3000, "value_text": "more than 3,000", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "Centers for Medicare & Medicaid Services", "org_short_name": "CMS", "org_url": "https://www.cms.gov", "org_tier": 1, "document_title": "Data", "document_url": "https://www.cms.gov/newsroom/data", "document_type": "press_release", "locator": "Medicare provider utilization & payment data: Inpatient Hospital Public Use File (PUF)", "quote": "This data includes hospital-specific charges for the more than 3,000 U.S. hospitals that receive Medicare Inpatient Prospective Payment System (IPPS) payments for the top 100 most frequently billed discharges.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "Centers for Medicare & Medicaid Services. (2012). Data. Retrieved September 16, 2026, from https://www.cms.gov/newsroom/data. Via StatOrigin, https://statorigin.org/stat/stat_D5KJDM50FGMCBZ224977H5YHBE", "bibtex": "@misc{cms2012hospitalsh5yhbe,\n author = {{Centers for Medicare \\& Medicaid Services}},\n title = {Data},\n year = {2012},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_D5KJDM50FGMCBZ224977H5YHBE},\n note = {Original source: https://www.cms.gov/newsroom/data. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_0AW23RY06NC54W4A71BJV93MMC", "url": "https://statorigin.org/stat/stat_0AW23RY06NC54W4A71BJV93MMC", "indicator": { "slug": "kindergarten-vaccination-coverage-decline", "name": "Kindergarten vaccination coverage decline", "definition": "The year-over-year percentage point decline in vaccination coverage among children entering kindergarten." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "US", "name": "United States", "type": "country" }, "period": { "start": "2025-08-01", "end": "2026-06-30", "type": "year" }, "value": 0.1, "value_text": "0.1 percent", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "Centers for Disease Control and Prevention", "org_short_name": "CDC", "org_url": "https://www.cdc.gov", "org_tier": 1, "document_title": "CDC Statement on Newly Released Kindergarten Vaccination Data", "document_url": "https://www.cdc.gov/media/releases/2026/cdc-statement-on-newly-released-kindergarten-vaccination-data.html", "document_type": "press_release", "locator": "STATEMENT", "quote": "The latest data show a 0.1 percent decline in vaccination coverage among children entering kindergarten.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "Centers for Disease Control and Prevention. (2026). CDC Statement on Newly Released Kindergarten Vaccination Data. Retrieved September 16, 2026, from https://www.cdc.gov/media/releases/2026/cdc-statement-on-newly-released-kindergarten-vaccination-data.html. Via StatOrigin, https://statorigin.org/stat/stat_0AW23RY06NC54W4A71BJV93MMC", "bibtex": "@misc{cdc2026kindergartenv93mmc,\n author = {{Centers for Disease Control and Prevention}},\n title = {CDC Statement on Newly Released Kindergarten Vaccination Data},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_0AW23RY06NC54W4A71BJV93MMC},\n note = {Original source: https://www.cdc.gov/media/releases/2026/cdc-statement-on-newly-released-kindergarten-vaccination-data.html. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_88810R303PH73F8FKJSETXM2AK", "url": "https://statorigin.org/stat/stat_88810R303PH73F8FKJSETXM2AK", "indicator": { "slug": "lung-cancer-screening-rate-among-eligible-program-members", "name": "Lung cancer screening rate among eligible program members", "definition": "Share of eligible WTC Health Program members meeting U.S. Preventive Services Task Force criteria who underwent lung cancer screening." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "US", "name": "United States", "type": "country" }, "period": { "start": "2024-01-01", "end": "2024-12-31", "type": "year" }, "value": 54, "value_text": "54%", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "Centers for Disease Control and Prevention", "org_short_name": "CDC", "org_url": "https://www.cdc.gov", "org_tier": 1, "document_title": "Twenty-Five Years After 9/11", "document_url": "https://www.cdc.gov/media/releases/2026/twenty-five-years-after-9-11-lessons-from-the-world-trade-center-health-program.html", "document_type": "press_release", "locator": "WTC Health Program lung cancer screening findings", "quote": "In 2024, 54% of eligible Program members who met U.S. Preventive Services Task Force criteria underwent lung cancer screening.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "Centers for Disease Control and Prevention. (2024). Twenty-Five Years After 9/11. Retrieved September 16, 2026, from https://www.cdc.gov/media/releases/2026/twenty-five-years-after-9-11-lessons-from-the-world-trade-center-health-program.html. Via StatOrigin, https://statorigin.org/stat/stat_88810R303PH73F8FKJSETXM2AK", "bibtex": "@misc{cdc2024lungtxm2ak,\n author = {{Centers for Disease Control and Prevention}},\n title = {Twenty-Five Years After 9/11},\n year = {2024},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_88810R303PH73F8FKJSETXM2AK},\n note = {Original source: https://www.cdc.gov/media/releases/2026/twenty-five-years-after-9-11-lessons-from-the-world-trade-center-health-program.html. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_TMYMJG1K6VZATX2DNZXJ0D0SYM", "url": "https://statorigin.org/stat/stat_TMYMJG1K6VZATX2DNZXJ0D0SYM", "indicator": { "slug": "manufacture-of-medicines-producer-price-index-growth-rate-monthly", "name": "Manufacture of medicines producer price index growth rate (monthly)", "definition": "Month-on-month percentage change in producer prices for the manufacture of medicines (pharmaceuticals) industry." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2026-08-01", "end": "2026-08-31", "type": "month" }, "value": -0.2, "value_text": "-0.2", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "National Bureau of Statistics of China", "org_short_name": "NBS China", "org_url": "https://www.stats.gov.cn", "org_tier": 1, "document_title": "Industrial Producer Price Indexes in August 2026", "document_url": "https://www.stats.gov.cn/english/PressRelease/202609/t20260910_1965274.html", "document_type": "press_release", "locator": "Table: Industrial Producer Price Indexes in August 2026 — III. Producer Price Indexes for Major Industries (Growth Rate M/M column)", "quote": "Manufacture of medicines -0.2 -3.7 -4.4", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "National Bureau of Statistics of China. (2026). Industrial Producer Price Indexes in August 2026. Retrieved September 15, 2026, from https://www.stats.gov.cn/english/PressRelease/202609/t20260910_1965274.html. Via StatOrigin, https://statorigin.org/stat/stat_TMYMJG1K6VZATX2DNZXJ0D0SYM", "bibtex": "@misc{nbschina2026manufacture0d0sym,\n author = {{National Bureau of Statistics of China}},\n title = {Industrial Producer Price Indexes in August 2026},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_TMYMJG1K6VZATX2DNZXJ0D0SYM},\n note = {Original source: https://www.stats.gov.cn/english/PressRelease/202609/t20260910\\_1965274.html. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_PH6A357PQS56C9R19MNBT8NN7E", "url": "https://statorigin.org/stat/stat_PH6A357PQS56C9R19MNBT8NN7E", "indicator": { "slug": "manufacture-of-medicines-producer-price-index-growth-rate-monthly", "name": "Manufacture of medicines producer price index growth rate (monthly)", "definition": "Month-on-month percentage change in producer prices for the manufacture of medicines (pharmaceuticals) industry." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "CN", "name": "China", "type": "country" }, "period": { "start": "2026-01-01", "end": "2026-08-31", "type": "point" }, "value": -4.4, "value_text": "-4.4", "unit": "percent", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "National Bureau of Statistics of China", "org_short_name": "NBS China", "org_url": "https://www.stats.gov.cn", "org_tier": 1, "document_title": "Industrial Producer Price Indexes in August 2026", "document_url": "https://www.stats.gov.cn/english/PressRelease/202609/t20260910_1965274.html", "document_type": "press_release", "locator": "Table: Industrial Producer Price Indexes in August 2026 — III. Producer Price Indexes for Major Industries (Jan-Aug Growth Rate Y/Y column)", "quote": "Manufacture of medicines -0.2 -3.7 -4.4", "published_date": null, "accessed_at": "2026-09-15", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "National Bureau of Statistics of China. (2026). Industrial Producer Price Indexes in August 2026. Retrieved September 15, 2026, from https://www.stats.gov.cn/english/PressRelease/202609/t20260910_1965274.html. Via StatOrigin, https://statorigin.org/stat/stat_PH6A357PQS56C9R19MNBT8NN7E", "bibtex": "@misc{nbschina2026manufacturet8nn7e,\n author = {{National Bureau of Statistics of China}},\n title = {Industrial Producer Price Indexes in August 2026},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_PH6A357PQS56C9R19MNBT8NN7E},\n note = {Original source: https://www.stats.gov.cn/english/PressRelease/202609/t20260910\\_1965274.html. Accessed September 15, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" }, { "id": "stat_WB7RD284XJX5KG0BFBYTJNVZTA", "url": "https://statorigin.org/stat/stat_WB7RD284XJX5KG0BFBYTJNVZTA", "indicator": { "slug": "market-shaping-strategy-interventions", "name": "Market shaping strategy interventions", "definition": "Number of interlinked interventions set out in the childhood cancer medicines market shaping strategy 2026-2030." }, "industry": [ { "slug": "healthcare", "name": "Human health activities", "isic": "Q86", "is_primary": true } ], "region": { "code": "GLOBAL", "name": "Global", "type": "world" }, "period": { "start": "2026-09-15", "end": "2026-09-15", "type": "point" }, "value": 10, "value_text": "ten", "unit": "count", "currency": null, "scale": "1", "value_type": "actual", "source": { "org": "World Health Organization", "org_short_name": "WHO", "org_url": "https://www.who.int", "org_tier": 1, "document_title": "New strategy to build a healthier market for childhood cancer medicines", "document_url": "https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines", "document_type": "press_release", "locator": "New strategy to build a healthier market for childhood cancer medicines", "quote": "To address these challenges, the strategy sets out ten interlinked interventions ordered such that near-term actions including broadening the quality-assured supplier base, consolidating demand via pooled procurement and published forecasts, and deploying volume guarantees to create conditions for regulatory reliance, integration of these medicines into nationally financed benefit packages, and, ultimately, voluntary licensing for newer therapies.", "published_date": null, "accessed_at": "2026-09-16", "license": "see-source", "url_status": "ok" }, "verification": "verified", "verified_by": "seed:auto-extract-v1", "verified_at": "2026-09-17T01:20:11.850Z", "confidence": 0.9, "is_secondhand": false, "supersedes": null, "superseded_by": null, "is_current": true, "citation": { "apa": "World Health Organization. (2026). New strategy to build a healthier market for childhood cancer medicines. Retrieved September 16, 2026, from https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines. Via StatOrigin, https://statorigin.org/stat/stat_WB7RD284XJX5KG0BFBYTJNVZTA", "bibtex": "@misc{who2026marketjnvzta,\n author = {{World Health Organization}},\n title = {New strategy to build a healthier market for childhood cancer medicines},\n year = {2026},\n howpublished = {StatOrigin, https://statorigin.org},\n url = {https://statorigin.org/stat/stat_WB7RD284XJX5KG0BFBYTJNVZTA},\n note = {Original source: https://www.who.int/news/item/15-09-2026-new-strategy-to-build-a-healthier-market-for-childhood-cancer-medicines. Accessed September 16, 2026.}\n}" }, "updated_at": "2026-09-17T01:20:11.850Z" } ], "meta": { "attribution": "Data from StatOrigin (https://statorigin.org), CC BY 4.0. Attribution required.", "license": "https://creativecommons.org/licenses/by/4.0/", "docs": "https://statorigin.org/docs/api", "total": 140, "limit": 50, "next_cursor": "eyJvIjo1MH0=" } }